SecBot SecBot
144 ·Filed Oct 8, 2026

HQY

HEALTHEQUITY, INC.
NEUTRAL
Impact 2/10
Horizonimmediate Processed1mo ago SEC0002076763-26-000009
Form 144, notice of proposed sale of securities
Actionable Insight • Neutral

This is a routine tax-withholding sale with no discretionary signal. Monitor for any subsequent Form 4 filings showing actual execution, but no further action warranted.

DirectionNeutral
Confidencehigh
Horizonimmediate

How the stock moved after the report

⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+20
Entry
$92.61
T+0 close · Oct 8, 2026 · via day close
Latest settled
+11.90%
T+20 · $103.63 · next T+60 in 7w
Vs SPY
+17.46%
α at T+20
Latest observation
+11.34%
T+26 · FF3 residual α
  1. T+0 · Oct 9 $92.61entry
  2. T+1 · 5w ago −0.63%α −0.57% · $92.03
  3. T+5 · 5w ago −0.63%α +1.34% · $92.03
  4. T+20 · 11d ago +11.90%α +17.46% · $103.63
  5. T+26 · todayOpen
  6. T+60 · in 7w Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Michael Gathright, an officer of HealthEquity, filed a Form 144 notice of intent to sell 662 shares of common stock, with an estimated aggregate market value of approximately $60,345. The sale is described as a mandatory 'sell to cover' transaction to satisfy tax withholding obligations under the company's equity incentive plan, not a discretionary trade. This is a routine, small-dollar insider sale with no material signal for the stock.

Key Facts

  • Filer: Michael Gathright, an officer of HealthEquity, Inc.
  • Proposed sale: 662 shares of common stock.
  • Estimated market value: ~$60,345 (based on 662 shares × ~$91.17 per share from the filing's reference price).
  • Sale type: Mandatory 'sell to cover' for tax withholding under the equity incentive plan, not a discretionary trade.
  • Filing date: October 8, 2026.
  • Broker: Morgan Stanley Smith Barney.

Financial Impact

Approximately $60,345 in shares proposed for sale, representing a negligible fraction of the company's market cap.

dilutioninsider holdings

Risk Factors

  • None, the sale is mandatory and non-discretionary.

Investment Themes

Software & IT

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0002076763-26-000009
Document: 0002076763-26-000009-index.html0002076763-26-000009
Document: 0002076763-26-000009.txt0002076763-26-000009

Track record

20 reports on HQY

Performance horizon

The track record builds as more bullish or bearish reports settle.

Filters
  1. Nov 3, 202613d ago Press Release Neutral 2/10 Entry $108.84 Now $104.58 −3.91% settles Dec 3
  2. Oct 27, 202620d ago Institutional Cluster Neutral 3/10 Entry $100.88 Now $104.58 +3.67% settles Nov 24
  3. Oct 19, 202628d ago Insider Cluster Neutral 2/10 Entry $96.60 Now $104.58 +8.26% settles Nov 17
  4. Oct 9, 20265w ago 8-K Neutral 2/10 Entry $92.03 to $102.11 Now $104.58 +13.64% ▲ +10.95% +14.22% vs SPY
  5. Oct 9, 20265w ago SC 13G/A Neutral 3/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
  6. Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
  7. Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
  8. Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
  9. Oct 8, 20265w ago 144 Neutral 2/10 Viewing Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
  10. Oct 8, 20265w ago 144 Neutral 2/10 Entry $92.61 to $103.63 Now $104.58 +12.93% ▲ +11.90% +17.46% vs SPY
Showing 10 of 20

US Market Status

Market Closed · Opens in 9h 10m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Oct 8, 2026